Yaqun Li

466 total citations · 1 hit paper
10 papers, 320 citations indexed

About

Yaqun Li is a scholar working on Oncology, Physiology and Molecular Biology. According to data from OpenAlex, Yaqun Li has authored 10 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Yaqun Li's work include Pain Mechanisms and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yaqun Li is often cited by papers focused on Pain Mechanisms and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Mechanisms and Therapy (2 papers). Yaqun Li collaborates with scholars based in China and South Korea. Yaqun Li's co-authors include Zichao Chen, Wenjie Zhao, Zhen Zhang, Jinhua Liu, Jibiao Wu, Dongmei Qi, Jinhua Liu, Hyung Gon Lee, Seung Hoon Kim and Myung Ha Yoon and has published in prestigious journals such as Journal of Controlled Release, Journal of Ethnopharmacology and Experimental Neurology.

In The Last Decade

Yaqun Li

8 papers receiving 317 citations

Hit Papers

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaqun Li China 5 182 113 106 58 36 10 320
Pan Chen China 5 138 0.8× 115 1.0× 122 1.2× 70 1.2× 71 2.0× 14 350
László Márkász Sweden 10 184 1.0× 121 1.1× 107 1.0× 62 1.1× 30 0.8× 23 379
Shaochuan Liu China 9 237 1.3× 121 1.1× 106 1.0× 89 1.5× 54 1.5× 15 362
Wenda Ye United States 7 117 0.6× 106 0.9× 92 0.9× 65 1.1× 39 1.1× 11 327
Mu Yan Cai China 7 190 1.0× 187 1.7× 115 1.1× 57 1.0× 41 1.1× 7 392
Hui Guan China 8 180 1.0× 125 1.1× 112 1.1× 94 1.6× 72 2.0× 26 426
Colin Snyder United States 6 205 1.1× 186 1.6× 128 1.2× 69 1.2× 55 1.5× 11 384
Minae An South Korea 6 189 1.0× 79 0.7× 110 1.0× 95 1.6× 49 1.4× 10 309
Jinen Song China 10 222 1.2× 157 1.4× 159 1.5× 63 1.1× 92 2.6× 14 439

Countries citing papers authored by Yaqun Li

Since Specialization
Citations

This map shows the geographic impact of Yaqun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqun Li more than expected).

Fields of papers citing papers by Yaqun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaqun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqun Li. The network helps show where Yaqun Li may publish in the future.

Co-authorship network of co-authors of Yaqun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yaqun Li. A scholar is included among the top collaborators of Yaqun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaqun Li. Yaqun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Li, Yaqun, et al.. (2025). Elucidating the mechanistic role of Rip3 in post-thalamic hemorrhage neurological deficits. Experimental Neurology. 392. 115373–115373.
3.
Zhao, Wenjie, Zhenyong Zhang, Zichao Chen, et al.. (2023). Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway. Journal of Ethnopharmacology. 318(Pt A). 116948–116948. 9 indexed citations
4.
Li, Yaqun, et al.. (2023). Antinociceptive effects of nefopam activating descending serotonergic modulation via 5‐HT2 receptors in the nucleus raphe magnus. European Journal of Pain. 28(2). 252–262. 1 indexed citations
5.
Li, Yaqun, et al.. (2022). A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. PeerJ. 10. e14432–e14432. 3 indexed citations
6.
Liu, Jinhua, Zichao Chen, Yaqun Li, et al.. (2021). PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Frontiers in Pharmacology. 12. 731798–731798. 275 indexed citations breakdown →
7.
Zhao, Wenjie, Jinhua Liu, Yaqun Li, et al.. (2021). Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer. Frontiers in Pharmacology. 12. 731741–731741. 15 indexed citations
8.
Li, Yaqun, Seung Hoon Kim, Hyung Gon Lee, et al.. (2020). Antinociceptive effects of nefopam modulating serotonergic, adrenergic, and glutamatergic neurotransmission in the spinal cord. Neuroscience Letters. 731. 135057–135057. 8 indexed citations
9.
Li, Yaqun, Woong Mo Kim, Hyung Gon Lee, et al.. (2020). Systemically administered neurotensin receptor agonist produces antinociception through activation of spinally projecting serotonergic neurons in the rostral ventromedial medulla. The Korean journal of pain. 34(1). 58–65. 3 indexed citations
10.
Li, Yaqun, Woong Mo Kim, Seung Hoon Kim, et al.. (2020). Prostaglandin D2 contributes to cisplatin-induced neuropathic pain in rats via DP2 receptor in the spinal cord. The Korean journal of pain. 34(1). 27–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026